Dr. Monte Edward Martin, MD

Dr. Martin practices at Taylor Regional Hospital in Campbellsville, Kentucky, part of Taylor Regional Hospital.

Dr. Martin's NPI, 1821138686, was assigned on February 8, 2007. Dr. Martin holds Kentucky license 38668.

Dr. Martin's primary practice is Taylor Regional Hospital, at 1700 Old Lebanon Road, Campbellsville, KY 42718 in Taylor County. The practice phone is (270) 465-3561.

Dr. Martin's primary practice is Taylor Regional Hospital in Campbellsville, Kentucky, part of Taylor Regional Hospital. Dr. Martin is also affiliated with CommonSpirit - Saint Joseph Hospital - Bardstown. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Martin to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Martin practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Martin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Martin is licensed in Kentucky.

CMS data shows 414 Medicare services from Dr. Martin across 4 procedure codes in 2024, all of them office visits, for 230 Medicare patients. Medicare paid $28,953 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 230 Medicare patients who saw Dr. Martin in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Martin's median patient age at 73, with 56% women.

In 2024, Dr. Martin wrote 471 Medicare Part D claims for 146 patients. 87% of them were for generic drugs. CMS names the drug for 285 of them, across 13 drugs with 11 or more claims each, at $15,797 in total drug cost. In 2023, CMS named 860 claims across 25 drugs.

Dr. Martin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Martin to 1 clinical trial. Conditions studied include Small Cell Lung Carcinoma and Carcinoma, Bronchogenic.

CMS Open Payments shows 1,321 general payments to Dr. Martin from 79 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Merck Sharp & Dohme Corporation paid the most, $5,256.